How the direct oral anticoagulant apixaban affects thrombin generation parameters

Area of Science:

• Pharmacology
• Hematology
• Biochemistry

Background:

• Direct oral anticoagulants (DOACs) like apixaban target Factor Xa to inhibit thrombin generation.
• Limited data exists on apixaban's specific effects on thrombin generation parameters.

Purpose of the Study:

• To investigate the influence of apixaban on key coagulation tests and thrombin generation parameters.
• To elucidate the detailed mechanism of action of apixaban in vitro.

Main Methods:

• Pooled normal plasma was incubated with varying concentrations of apixaban.
• Assays included prothrombin time (PT), activated partial thromboplastin time (APTT), and detailed thrombin generation analysis.
• Measurements were performed with and without thrombomodulin to assess its influence.

Main Results:

• Apixaban showed minimal impact on PT and APTT.
• All measured thrombin generation parameters were affected: lag-time increased, while endogenous thrombin potential (ETP) and thrombin-peak decreased.
• These effects were more pronounced in the presence of thrombomodulin, reducing the with/without ratio.

Conclusions:

• Apixaban demonstrates significant antithrombotic properties by modulating thrombin generation.
• Thrombin generation assays can serve as a valuable tool for assessing anticoagulant activity and comparing DOACs.